Beijing Bio and Beijing Kexing Zhongwei both entrusted other biological products Co., Ltd. as packaging and preparation enterprises, and expanded the production capacity of COVID-19 vaccine through packaging.
Beijing Bio entrusts Changchun Bio-Changchun Qijian Biological Products Co., Ltd. as a sub-packaging enterprise, and Beijing Kexing Zhongwei entrusts Kexing Dalian Vaccine Technology Co., Ltd. and Beijing Kexing Biological Products Co., Ltd. as sub-packaging and sub-packaging enterprises.
Although the packaging company is different, the stock solution of COVID-19 vaccine is produced by Beijing Bio or Beijing Kexing Zhongwei, so the quality and safety can be completely assured, so they are all inactivated vaccines, which can be inoculated by any brand without any problems.
About Kexing
Kexing Holding Biotechnology Co., Ltd. (referred to as "Kexing") is a high-tech biotechnology enterprise headquartered in Beijing and currently listed on SVA Nasdaq.
The company owns Beijing Kexing Biological Products Co., Ltd. (hereinafter referred to as "Beijing Kexing"), Kexing (Dalian) Vaccine Technology Co., Ltd. (hereinafter referred to as "Dalian Kexing"), Beijing Kexing Zhongwei Biotechnology Co., Ltd. (hereinafter referred to as "Kexing Zhongwei") and Beijing Kexing Zhong Yi Biomedical Co., Ltd. (hereinafter referred to as "Kexing Zhong Yi") through wholly-owned subsidiaries.